Metropolis Healthcare reported 9.84% growth in total revenues for the Dec-20 quarter on consolidated basis at Rs244.78cr. The healthcare testing and diagnostic segment has assumed a lot of significance in the post-COVID scenario and that is evident in the rising sales revenues for the quarter. Even as the vaccination drive commences across India, the need for testing centres is only going to swell.
The consolidated Profit after tax (PAT) for the Dec-20 quarter was up 39.42% at Rs58.57cr. PAT benefited from higher revenues and other income such that the impact of the top line got magnified on the bottom line. The company also saw lower financing charges in the quarter. As a result, the PAT margins improved from 18.85% in Dec-19 to 23.93% in Dec-20.
Financial highlights for Dec-20 compared yoy and sequentially
|
|
Metropolis Healthcare |
|
|
|
|
|
Rs in Crore |
Dec-20 |
Dec-19 |
YOY |
Sep-20 |
QOQ |
|
Total Income (Rs cr) |
₹ 244.78 |
₹ 222.85 |
9.84% |
₹ 288.35 |
-15.11% |
|
Net Profit (Rs cr) |
₹ 58.57 |
₹ 42.01 |
39.42% |
₹ 60.28 |
-2.84% |
|
|
|
|
|
|
|
|
Diluted EPS (Rs) |
₹ 11.46 |
₹ 8.37 |
|
₹ 11.80 |
|
|
Net Margins |
23.93% |
18.85% |
|
20.91% |
|
Related Tags: